Jinling Pharmaceutical Company Limited (SHE:000919)

Market Cap	4.33B
Revenue (ttm)	3.25B
Net Income (ttm)	18.27M
Shares Out	623.71M
EPS (ttm)	0.03
PE Ratio	235.75
Forward PE	n/a
Dividend	0.10 (1.43%)
Ex-Dividend Date	May 31, 2024

Volume	6,515,300
Average Volume	10,990,223
Open	6.82
Previous Close	6.97
Day's Range	6.82 - 7.01
52-Week Range	5.55 - 7.85
Beta	0.57
RSI	59.20
Earnings Date	Aug 28, 2025

About SHE:000919

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products and medical devices in China. The company provides Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, polyarteritis, acute arterial embolism of extremities, diabetic gangrene, intravenous thrombus, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; lentinan injection for the treatment of malignant tumors; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 5,789
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000919

Financial Performance

In 2024, SHE:000919's revenue was 3.28 billion, an increase of 2.74% compared to the previous year's 3.19 billion. Earnings were 40.41 million, a decrease of -61.95%.